Maintenance Capecitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma-Magic Bullet or Pandora's Box? Reply

被引：1
|
作者：
Hope, Thomas A. [1 ,2 ,3 ]
Calais, Jeremie [4 ,5 ]
机构：
[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 185 Berry St,Ste 350, San Francisco, CA 94107 USA
[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[3] San Francisco VA Med Ctr, Dept Radiol & Biomed Imaging, San Francisco, CA USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Ahmanson Translat Theranost Div, Los Angeles, CA 90095 USA
[5] Univ Duisburg Essen, German Canc Consortium DKTK, Univ Hosp Essen, Dept Nucl Med, Essen, Germany
来源：
JAMA ONCOLOGY | 2022年 / 8卷 / 04期
关键词：
D O I：
10.1001/jamaoncol.2021.7994
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：644 / 645
页数：1
相关论文
共 27 条
  • [1] Maintenance Capecitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma-Magic Bullet or Pandora's Box?
    Ng, Wai-Tong
    Chua, Melvin L. K.
    Lee, Anne W. M.
    JAMA ONCOLOGY, 2022, 8 (04) : 524 - 525
  • [2] Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma
    Ganguly, Shuvadeep
    Gogia, Ajay
    JAMA ONCOLOGY, 2022, 8 (08) : 1223 - 1224
  • [3] Capecitabine monotherapy for recurrent and metastatic nasopharyngeal carcinoma
    Mehdi, A.
    Hela, R.
    ORAL ONCOLOGY, 2009, : 191 - 191
  • [4] Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma
    Twu, Chih-Wen
    Lin, Po-Ju
    Tsou, Hsiao-Hui
    Liu, Yi-Chun
    Jiang, Rong-San
    Liang, Kai-Li
    Lin, Tian-Yun
    Wang, Wen-Yi
    Lin, Jin-Ching
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (06): : 1453 - 1461
  • [5] Maintenance metronomic chemotherapy for recurrent/metastatic nasopharyngeal carcinoma
    Wu, C.
    Wang, W. Y.
    Twu, C. W.
    Lin, P. J.
    Liu, Y. C.
    Lin, J. C.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S515 - S515
  • [6] The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study
    Sun, Xue-Song
    Liu, Sai-Lan
    Liang, Yu-Jing
    Chen, Qiu-Yan
    Li, Xiao-Yun
    Tang, Lin-Quan
    Mai, Hai-Qiang
    CANCER COMMUNICATIONS, 2020, 40 (01) : 32 - 42
  • [7] A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy
    Chua, DTT
    Sham, JST
    Au, GKH
    ORAL ONCOLOGY, 2003, 39 (04) : 361 - 366
  • [8] Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience
    Guo, Qiaojuan
    Chen, Mengwei
    Xu, Hanchuan
    Lu, Tianzhu
    Zhou, Han
    Chen, Yanyan
    Zong, Jingfeng
    Xu, Yun
    Chen, Bijuan
    Wang, Bingyi
    Zhu, Lili
    Pan, Jianji
    Lin, Shaojun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 1387 - 1396
  • [9] The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial
    Tang, Lin-Quan
    Li, Xiao-Yun
    Li, Zhi-Ming
    Liu, Zhi-Gang
    Lin, Miao-Zhen
    Zhou, Huan
    Yu, Qi-Wen
    Zhou, Jian
    Zhao, Chong
    Chen, Ze-Bin
    Wang, Xi-Cheng
    Peng, Jia-Yu
    Chen, Qiu-Yan
    Fang, Wen-Feng
    Yang, Yun-Peng
    Zhang, Bei
    Xia, Liang-Ping
    Hu, Pi-Li
    Hu, Wei-Han
    Li, Yi-Jie
    Mai, Hai-Qiang
    Cai, Xiu-Yu
    BMC MEDICINE, 2023, 21 (01)
  • [10] The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial
    Lin-Quan Tang
    Xiao-Yun Li
    Zhi-Ming Li
    Zhi-Gang Liu
    Miao-Zhen Lin
    Huan Zhou
    Qi-Wen Yu
    Jian Zhou
    Chong Zhao
    Ze-Bin Chen
    Xi-Cheng Wang
    Jia-Yu Peng
    Qiu-Yan Chen
    Wen-Feng Fang
    Yun-Peng Yang
    Bei Zhang
    Liang-Ping Xia
    Pi-Li Hu
    Wei-Han Hu
    Yi-Jie Li
    Hai-Qiang Mai
    Xiu-Yu Cai
    BMC Medicine, 21
123